Waddill William D.'s Form 4 filing
Protagonist Therapeutics, Inc (PTGX) · filed Jun 11, 2026
- Accession no.
- 0001104659-26-073049
- Filed
- Jun 11, 2026
- Trade date
- Jun 10, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $969.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Waddill William D.CIK 0001553338 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | Common Stock | MOption exerciseAcquired | +3,000 | $11.80 | +$35,400 | 10,825 | Direct | |
| Jun 10, 2026 | Common Stock | MOption exerciseAcquired | +6,000 | $16.54 | +$99,240 | 16,825 | Direct | |
| Jun 10, 2026 | Common Stock | SSaleDisposed | −9,000 | $107.68 | −$969,120 | 7,825 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | Common Stock | MOption exerciseDisposed | −3,000 | $0.00 | $0 | 0 | Direct | |
| Jun 10, 2026 | Common Stock | MOption exerciseDisposed | −6,000 | $0.00 | $0 | 9,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.